Bipolar Research Today is a free monthly online journal that collates and summarizes the latest research about Bipolar, including details on bipolar disorder, symptoms, treatment, depression, medication.

Volume 7 (2010), Issue 5 (May)

1. Pediatric bipolar disorder: evidence for prodromal states and early markers.
   J Child Psychol Psychiatry, 51(4): 459-71. [Abstract] [Full-text]
2. Impaired sustained attention and executive dysfunction: bipolar disorder versus depression-specific markers of affective disorders.
   Neuropsychologia, 48(6): 1862-8. [Abstract] [Full-text]
3. Research in people with psychosis risk syndrome: a review of the current evidence and future directions.
   J Child Psychol Psychiatry, 51(4): 390-431. [Abstract] [Full-text]
4. Association of GPR50, an X-linked orphan G protein-coupled receptor, and affective disorder in an independent sample of the Scottish population.
   Neurosci Lett, 475(3): 169-73. [Abstract] [Full-text]
5. Expression of the Rap1 guanine nucleotide exchange factor, MR-GEF, is altered in individuals with bipolar disorder.
   PLoS One, 5(4): e10392. [Abstract] [Full-text]
6. Preexisting comorbid psychiatric conditions and mortality in nonsurgical intensive care patients.
   Am J Crit Care, 19(3): 241-9. [Abstract] [Full-text]
7. Group-based psychosocial intervention for bipolar disorder: randomised controlled trial.
   Br J Psychiatry, 196(5): 383-8. [Abstract] [Full-text]
8. Brain networks: Foundations and futures in bipolar disorder.
   J Ment Health, 19(2): 157-67. [Abstract] [Full-text]
9. Predicting response to lithium in bipolar disorder: A critical review of pharmacogenetic studies.
   J Ment Health, 19(2): 142-56. [Abstract] [Full-text]
10. Anticonvulsants in bipolar disorder.
    J Ment Health, 19(2): 127-41. [Abstract] [Full-text]
11. Evidence and implications for early intervention in bipolar disorder.
    J Ment Health, 19(2): 113-26. [Abstract] [Full-text]
12. The involvement of GSK3beta in bipolar disorder: integrating evidence from multiple types of genetic studies.
    Eur Neuropsychopharmacol, 20(6): 357-68. [Abstract] [Full-text]
13. High occurrence of mood and anxiety disorders among older adults: The National Comorbidity Survey Replication.
    Arch Gen Psychiatry, 67(5): 489-96. [Abstract] [Full-text]
14. Characteristics of patients with bipolar disorder managed in VA primary care or specialty mental health care settings.
    Psychiatr Serv, 61(5): 500-7. [Abstract] [Full-text]
15. Patterns of injury and childhood psychiatric disorder in a low-income population.
    Community Ment Health J, 46(3): 221-30. [Abstract] [Full-text]
16. Anticipated Benefits of Care (ABC): psychometrics and predictive value in psychiatric disorders.
    Psychol Med, 40(6): 955-65. [Abstract] [Full-text]
17. Sense of hyper-positive self, goal-attainment beliefs and coping strategies in bipolar I disorder.
    Psychol Med, 40(6): 967-75. [Abstract] [Full-text]
18. Toxic keratopathy due to abuse of topical anesthetic drugs.
    Cutan Ocul Toxicol, 29(2): 105-9. [Abstract] [Full-text]
19. Subjective and objective indicators of recovery in severe mental illness: a cross-sectional study.
    Int J Soc Psychiatry, 56(3): 220-9. [Abstract] [Full-text]
20. Lay theories of bipolar disorder: the causes, manifestations and cures for perceived bipolar disorder.
    Int J Soc Psychiatry, 56(3): 255-69. [Abstract] [Full-text]
21. Increased plasma levels of soluble TNF receptor I in patients with bipolar disorder.
    Eur Arch Psychiatry Clin Neurosci. [Abstract] [Full-text]
22. The effects of kappa-opioid receptor ligands on prepulse inhibition and CRF-induced prepulse inhibition deficits in the rat.
    Psychopharmacology (Berl), 210(2): 231-40. [Abstract] [Full-text]
23. Von Economo neuron density in the anterior cingulate cortex is reduced in early onset schizophrenia.
    Acta Neuropathol, 119(6): 771-8. [Abstract] [Full-text]
24. Investigation into activation of dysfunctional schemas in euthymic bipolar disorder following positive mood induction.
    Br J Clin Psychol. [Abstract] [Full-text]
25. Interpersonal and social rhythm therapy for adolescents with bipolar disorder: treatment development and results from an open trial.
    Depress Anxiety, 27(5): 457-64. [Abstract] [Full-text]
26. Indirect costs associated with nonadherence to treatment for bipolar disorder.
    J Occup Environ Med, 52(5): 478-85. [Abstract] [Full-text]
27. Strategies to identify genes for complex disorders: a focus on bipolar disorder and chromosome 16p.
    Psychiatr Genet. [Abstract] [Full-text]
28. Use of thalidomide for severe recurrent aphthous stomatitis: a multicenter cohort analysis.
    Medicine (Baltimore), 89(3): 176-82. [Abstract] [Full-text]
29. Markers of glutamate synaptic transmission and plasticity are increased in the anterior cingulate cortex in bipolar disorder.
    Biol Psychiatry, 67(11): 1010-6. [Abstract] [Full-text]
30. Possible association of different G72/G30 SNPs with mood episodes and persecutory delusions in bipolar I Romanian patients.
    Prog Neuropsychopharmacol Biol Psychiatry, 34(4): 657-63. [Abstract] [Full-text]
31. Voxelwise meta-analysis of gray matter abnormalities in bipolar disorder.
    Biol Psychiatry, 67(11): 1097-105. [Abstract] [Full-text]
32. Gender differences in subjective experience and treatment of bipolar disorder.
    J Nerv Ment Dis, 198(5): 370-2. [Abstract] [Full-text]
33. Detecting differences in diagnostic assessment of bipolar disorder.
    J Nerv Ment Dis, 198(5): 339-42. [Abstract] [Full-text]
34. The Neuropsychiatric Phenotype in Darier Disease.
    Br J Dermatol. [Abstract] [Full-text]
35. Thought suppression in patients with bipolar disorder.
    J Abnorm Psychol, 119(2): 355-65. [Abstract] [Full-text]
36. Bipolar disorder and comorbid attention deficit hyperactivity disorder. A distinct clinical phenotype? Clinical characteristics and temperamental traits.
    World J Biol Psychiatry, 11(4): 656-66. [Abstract] [Full-text]
37. Twelve-month prospective, multinational, observational study of factors associated with recovery from mania in bipolar disorder in patients treated with atypical antipsychotics.
    World J Biol Psychiatry, 11(4): 667-76. [Abstract] [Full-text]
38. Reporting bias in medical research - a narrative review.
    Trials, 11: 37. [Abstract] [Full-text]
39. Psychometric properties of performance-based measurements of functional capacity: test-retest reliability, practice effects, and potential sensitivity to change.
    Schizophr Res, 119(1): 246-52. [Abstract] [Full-text]
40. Temperamentsxgenes in bipolar I and bipolar II disorder patients.
    Psychiatry Res, 177(3): 364-6. [Abstract] [Full-text]
41. Staging Bipolar Disorder.
    Neurotox Res. [Abstract] [Full-text]
42. Psychiatric 'diseases' versus behavioral disorders and degree of genetic influence.
    Psychol Med. [Abstract] [Full-text]
43. Evidence for association of the non-duplicated region of CHRNA7 gene with bipolar disorder but not with Schizophrenia.
    Psychiatr Genet. [Abstract] [Full-text]
44. Association between age of onset and mood in bipolar disorder: Comparison of subgroups identified by cluster analysis and clinical observation.
    J Psychiatr Res. [Abstract] [Full-text]
45. "I really don't know whether it is still there": ambivalent acceptance of a diagnosis of bipolar disorder.
    Psychiatr Q, 81(2): 157-65. [Abstract] [Full-text]
46. Levels of phosphodiesterase 4A and 4B are altered by chronic treatment with psychotropic medications in rat frontal cortex.
    Synapse, 64(7): 550-5. [Abstract] [Full-text]
47. The effect of seasons and seasonal variation on neuropsychological test performance in patients with bipolar I disorder and their first-degree relatives.
    J Affect Disord. [Abstract] [Full-text]
48. Effects of mood stabilizers on hippocampus and amygdala BDNF levels in an animal model of mania induced by ouabain.
    J Psychiatr Res, 44(8): 506-10. [Abstract] [Full-text]
49. TARPs differentially decorate AMPA receptors to specify neuropharmacology.
    Trends Neurosci, 33(5): 241-8. [Abstract] [Full-text]
50. Rapid modulation of TRH and TRH-like peptide release in rat brain, pancreas, and testis by a GSK-3beta inhibitor.
    Peptides, 31(6): 1083-93. [Abstract] [Full-text]
51. Assessment of safety, tolerability and effectiveness of adjunctive aripiprazole to lithium/valproate in bipolar mania: a 46-week, open-label extension following a 6-week double-blind study.
    Curr Med Res Opin, 26(6): 1485-96. [Abstract] [Full-text]
52. Association study between RGS4 and bipolar disorder in the Chinese Han population.
    Psychiatr Genet, 20(3): 130-2. [Abstract] [Full-text]
53. Family-based association study for bipolar affective disorder.
    Psychiatr Genet, 20(3): 126-9. [Abstract] [Full-text]
54. Support for a bipolar affective disorder susceptibility locus on chromosome 12q24.3.
    Psychiatr Genet, 20(3): 93-101. [Abstract] [Full-text]
55. The effect of Li(+) on GSK-3 inhibition: Molecular dynamics simulation.
    J Mol Model. [Abstract] [Full-text]
56. Positive aspects of mental illness: A review in bipolar disorder.
    J Affect Disord. [Abstract] [Full-text]
57. Hematological effects of valproate in psychiatric patients: what are the risk factors?
    J Clin Psychopharmacol, 30(3): 282-5. [Abstract] [Full-text]
58. Oral olanzapine disposition in adolescents with schizophrenia or bipolar I disorder: a population pharmacokinetic model.
    Paediatr Drugs, 12(3): 201-11. [Abstract] [Full-text]
59. The role of genetic variation of BDNF gene in antidepressant-induced mania in bipolar disorder.
    Psychiatry Res. [Abstract] [Full-text]
60. Increased risk of gout among patients with bipolar disorder: A nationwide population-based study.
    Psychiatry Res. [Abstract] [Full-text]
61. Risperidone long-acting injection: in bipolar I disorder.
    Drugs, 70(8): 1001-12. [Abstract] [Full-text]
62. Older adults with bipolar disorder.
    J Gerontol Nurs, 36(5): 20-7. [Abstract] [Full-text]
63. Chronic imipramine but not bupropion increases arachidonic acid signaling in rat brain: is this related to 'switching' in bipolar disorder?
    Mol Psychiatry, 15(6): 602-14. [Abstract] [Full-text]
64. Outcome and length of stay in psychiatric hospitalization, the experience of the University Clinic of Turin.
    Soc Psychiatry Psychiatr Epidemiol, 45(6): 603-10. [Abstract] [Full-text]
65. Social and clinical comparison between schizophrenia and bipolar disorder type I with psychosis in Costa Rica.
    Soc Psychiatry Psychiatr Epidemiol, 45(6): 675-80. [Abstract] [Full-text]
66. Screening for bipolar disorder during pregnancy and the postpartum period.
    Arch Womens Ment Health, 13(3): 233-48. [Abstract] [Full-text]
67. An association study between the Val66Met polymorphism of the BDNF gene and postpartum depression.
    Arch Womens Ment Health, 13(3): 285-9. [Abstract] [Full-text]
68. Animal models of virus-induced neurobehavioral sequelae: recent advances, methodological issues, and future prospects.
    Interdiscip Perspect Infect Dis, 2010: 380456. [Abstract] [Full-text]
69. Modulatory effect of cod-liver oil on Na+ -K + ATPase in rats' brain.
    Hum Exp Toxicol. [Abstract] [Full-text]
70. Lithium in bipolar and other affective disorders: prescribing practice in the UK.
    J Psychopharmacol. [Abstract] [Full-text]
71. White matter hyperintensities in affected and unaffected late teenage and early adulthood offspring of bipolar parents: A two-center high-risk study.
    J Psychiatr Res. [Abstract] [Full-text]
72. A randomized comparison of online and paper mood charts for people with bipolar disorder.
    J Affect Disord, 124(1): 85-9. [Abstract] [Full-text]
73. Adult ADHD and its comorbidities, with a focus on bipolar disorder.
    J Affect Disord, 124(1): 1-8. [Abstract] [Full-text]
74. A prospective study of the impact of subthreshold mixed states on the 24-month clinical outcomes of bipolar I disorder or schizoaffective disorder.
    J Affect Disord, 124(1): 22-8. [Abstract] [Full-text]
75. Age at onset of bipolar disorder in a Norwegian catchment area sample.
    J Affect Disord, 124(1): 174-7. [Abstract] [Full-text]
76. Early-onset Major Depressive Disorder in men is associated with childlessness.
    J Affect Disord, 124(1): 187-90. [Abstract] [Full-text]
77. Weight gain, obesity, and metabolic indices following a first manic episode: prospective 12-month data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM).
    J Affect Disord, 124(1): 108-17. [Abstract] [Full-text]
78. Altered levels of extracellular signal-regulated kinase signaling proteins in postmortem frontal cortex of individuals with mood disorders and schizophrenia.
    J Affect Disord, 124(1): 164-9. [Abstract] [Full-text]
79. What works for people with bipolar disorder? Tips from the experts.
    J Affect Disord, 124(1): 76-84. [Abstract] [Full-text]
80. Placebo-controlled study of quetiapine monotherapy in ambulatory bipolar spectrum disorder with moderate-to-severe hypomania or mild mania.
    J Affect Disord, 124(1): 157-63. [Abstract] [Full-text]
81. Disorder-specific psychosocial interventions for bipolar disorder--a systematic review of the evidence for mental health nursing practice.
    Int J Nurs Stud, 47(7): 896-908. [Abstract] [Full-text]
82. Dysfunction of the Scn8a voltage-gated sodium channel alters sleep architecture, reduces diurnal corticosterone levels, and enhances spatial memory.
    J Biol Chem, 285(22): 16553-61. [Abstract] [Full-text]
83. Persistent antipsychotic polypharmacy and excessive dosing in the community psychiatric treatment setting: a review of medication profiles in 435 Canadian outpatients.
    J Clin Psychiatry, 71(5): 566-73. [Abstract] [Full-text]
84. Randomized, double-blind, placebo-controlled study of divalproex extended release loading monotherapy in ambulatory bipolar spectrum disorder patients with moderate-to-severe hypomania or mild mania.
    J Clin Psychiatry, 71(5): 557-65. [Abstract] [Full-text]
85. Further evidence supporting the association between 5HTR2C gene and bipolar disorder.
    Psychiatry Res. [Abstract] [Full-text]
86. Time to rehospitalization in patients with major depression vs. those with schizophrenia or bipolar I disorder in a public psychiatric hospital.
    Psychiatry Res. [Abstract] [Full-text]
87. TAAR6 variations possibly associated with antidepressant response and suicidal behavior.
    Psychiatry Res. [Abstract] [Full-text]
88. The neurobiology of the switch process in bipolar disorder: a review.
    J Clin Psychiatry. [Abstract] [Full-text]
89. Metabolic syndrome in patients enrolled in a clinical trial of aripiprazole in the maintenance treatment of bipolar I disorder: a post hoc analysis of a randomized, double-blind, placebo-controlled trial.
    J Clin Psychiatry. [Abstract] [Full-text]
90. Insular cortex volume in established bipolar affective disorder: a preliminary MRI study.
    Psychiatry Res, 182(2): 187-90. [Abstract] [Full-text]
91. Brain glutamatergic characteristics of pediatric offspring of parents with bipolar disorder.
    Psychiatry Res, 182(2): 165-71. [Abstract] [Full-text]
92. Lithium ameliorates phenotypic deficits in a mouse model of fragile X syndrome.
    Int J Neuropsychopharmacol. [Abstract] [Full-text]
93. Predictors of response to electroconvulsive therapy obtained using the three-factor structure of the Montgomery and Asberg Depression Rating Scale for treatment-resistant depressed patients.
    J ECT, 26(2): 87-90. [Abstract] [Full-text]
94. Electroconvulsive therapy in the presence of a metallic skull plate after meningioma resection.
    J ECT, 26(2): 136-8. [Abstract] [Full-text]
95. A systematic association mapping on chromosome 6q in bipolar affective disorder--evidence for the melanin-concentrating-hormone-receptor-2 gene as a risk factor for bipolar affective disorder.
    Am J Med Genet B Neuropsychiatr Genet, 153(4): 878-84. [Abstract] [Full-text]
96. Functional variants of TSPAN8 are associated with bipolar disorder and schizophrenia.
    Am J Med Genet B Neuropsychiatr Genet, 153(4): 967-72. [Abstract] [Full-text]
97. Safety of the electroconvulsive therapy-ziprasidone combination.
    J ECT, 26(2): 139-42. [Abstract] [Full-text]
98. Coming to grips with complex disorders: genetic risk prediction in bipolar disorder using panels of genes identified through convergent functional genomics.
    Am J Med Genet B Neuropsychiatr Genet, 153(4): 850-77. [Abstract] [Full-text]
99. The Prevalence and Course of Pathological Gambling in the Mood Disorders.
    J Gambl Stud. [Abstract] [Full-text]
100. Increased neurotrophin-3 in drug-free subjects with bipolar disorder during manic and depressive episodes.
     J Psychiatr Res, 44(9): 561-5. [Abstract] [Full-text]
101. The mania-like exploratory profile in genetic dopamine transporter mouse models is diminished in a familiar environment and reinstated by subthreshold psychostimulant administration.
     Pharmacol Biochem Behav, 96(1): 7-15. [Abstract] [Full-text]
102. Intrusive memories and images in bipolar disorder.
     Behav Res Ther, 48(7): 698-703. [Abstract] [Full-text]
103. Hyperactivity and enhanced curiosity of mice expressing PKB/SGK-resistant glycogen synthase kinase-3 (GSK-3).
     Cell Physiol Biochem, 25(6): 775-86. [Abstract] [Full-text]
104. Perception of facial emotion in adults with bipolar or unipolar depression and controls.
     J Psychiatr Res. [Abstract] [Full-text]
105. Epigenetic Studies of Psychosis: Current Findings, Methodological Approaches, and Implications for Postmortem Research.
     Biol Psychiatry. [Abstract] [Full-text]
106. Psychosocial function in schizophrenia and bipolar disorder: Relationship to neurocognition and clinical symptoms.
     J Int Neuropsychol Soc. [Abstract] [Full-text]

© 2004-2013 Bipolar Research Today. All Rights Reserved.